Loading asset research
Gelteq Limited Ordinary Shares
GELSNasdaq · USD · StocksQuote as of · Exchange session not verified$0.55
-8.49%
Today
GELS
Loading 1D prices…
Market cap
$5.8M
Volume
284.8K
52w high
$2.0152w low
$0.387Company profile
Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
SOUTH MELBOURNE VIC, United States
Employees
7
Fiscal year end
0630
CIK
1920092
Session & valuation
Open$0.52
Previous close$0.601
Day high$0.585
Day low$0.52
30-day avg. volume6M
Outstanding shares9.4M
Diluted EPS-$0.72
Latest annual period
P/E (trailing)-0.76
P/E (forward)—
Price / book0.60
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KAPAKairos Pharma Ltd. Common Stock | $5.9M | $0.00 | — | -$0.30 | +2.31% | Buy |
| ACXPAcurx Pharmaceuticals Inc. Common Stock | $5.8M | $0.00 | — | -$5.32 | -0.73% | Buy |
| PULMPulmatrix Inc. Common Stock | $6M | $0.00 | — | -$1.41 | -0.89% | Unrated |
| DRMADermata Therapeutics Inc. Common Stock | $5.7M | $0.00 | — | -$8.16 | +4.46% | Buy |
| XBIOXenetic Biosciences Inc. Common Stock | $5.7M | $3M | -90.07% | -$1.58 | -1.98% | Unrated |